ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 731356 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 731356; 2) Community: the network communities that were significantly associated with the response to NSC 731356; 3) Molecule: the relationships between components within communities and NSC 731356; 4) MDR: the compounds that were significantly associated with the NSC 731356.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0285477013888565 0.27395465
NSC 300289 Pinafide 0.0285477013888565 0.35465232
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0285477013888565 0.09394002
NSC 328410 Camptothecin Derivative 0.0285477013888565 0.058833954
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0285477013888565 0.18825216
NSC 359239 Antibiotic X-14766A 0.0285477013888565 -0.25287848
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0285477013888565 -0.019118722
NSC 371777 Null 0.0285477013888565 0.023860216
NSC 617394 Null 0.0285477013888565 0.22576727
NSC 631371 N-(3,5-Dimethoxybenzyl)-4-methoxyaniline 0.0285477013888565 -0.20071921
Total:58  Current:33    [First] [Prev] [Next] [Last]